ACTIV-6

Projects & Initiatives

The purpose of the ACTIV-6 research study is to test medications that are already approved for other diseases to see if they can help people with mild to moderate COVID-19 feel better faster and stay out of the hospital.

How you can help?

If you answer "yes" to all of these questions, you might be able to take part in this study:

  • Are you at least 30 years old?
  • Have you tested positive for COVID-19 within the past 10 days?
  • Since testing positive, have you had at least 2 of these COVID-19 symptoms?
    • Feeling tired
    • Trouble breathing
    • Fever
    • Cough
    • Upset stomach
    • Vomiting
    • Diarrhea
    • Body aches or chills
    • Headache
    • Sore throat
    • Stuffy nose
    • New loss of sense of taste or smell

What is ACTIV-6?

The purpose of the ACTIV-6 research study is to test medications that are already approved for other diseases to see if they can help people with mild to moderate COVID-19 feel better faster and stay out of the hospital.

ACTIV-6 is part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program.

Why is this study being done?

Better treatments for COVID-19 are still needed, especially for patients with mild to moderate illness. This study is testing different medications because COVID-19 affects each person differently.

What will you do if you decide to participate?

  • Take either a study medication or placebo, as prescribed. A placebo is a medication that has no active ingredients and will have no effect.
  • Answer short surveys daily for 14-28 days. Surveys are taken online on a secure, private website. There are no in-person study visits.
  • Complete a follow-up survey after 90 days

The study drugs will be shipped to you at no cost. Surveys are taken online on a secure, private website. If you have questions, someone will be available to assist you. Participants may receive a gift card of up to a $100 upon completion of the study.

Enroll Today!

Visit activ6study.org to fill out a screening form or call (904) 244-4690 to speak with a study team member.